Connection

Yu-Tao Xiang to Schizophrenia

Back to Details
This is a "connection" page, showing publications Yu-Tao Xiang has written about Schizophrenia.
Yu-Tao Xiang
Connection Strength
6.286
Schizophrenia
  1. Antipsychotic Polypharmacy in Older Adult Asian Patients With Schizophrenia: Research on Asian Psychotropic Prescription Pattern. J Geriatr Psychiatry Neurol. 2019 11; 32(6):304-311.
    View in: PubMed
    Score: 0.384
  2. Adjunctive minocycline for major mental disorders: A systematic review. J Psychopharmacol. 2019 10; 33(10):1215-1226.
    View in: PubMed
    Score: 0.376
  3. Prevalence of suicide attempts in individuals with schizophrenia: a meta-analysis of observational studies. Epidemiol Psychiatr Sci. 2019 Jun 07; 29:e39.
    View in: PubMed
    Score: 0.374
  4. Quality of life in Chinese patients with schizophrenia: A meta-analysis. Psychiatry Res. 2018 10; 268:392-399.
    View in: PubMed
    Score: 0.352
  5. Physical comorbidities in older adults receiving antidepressants in Asia. Psychogeriatrics. 2018 Sep; 18(5):351-356.
    View in: PubMed
    Score: 0.351
  6. Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials. J Psychiatr Res. 2018 08; 103:244-251.
    View in: PubMed
    Score: 0.349
  7. Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials. Schizophr Res. 2018 07; 197:288-293.
    View in: PubMed
    Score: 0.341
  8. Adjunctive azapirone for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials. Eur Neuropsychopharmacol. 2018 01; 28(1):149-158.
    View in: PubMed
    Score: 0.336
  9. Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials. J Int Med Res. 2018 Jan; 46(1):22-32.
    View in: PubMed
    Score: 0.328
  10. Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review. Pharmacopsychiatry. 2018 May; 51(3):100-104.
    View in: PubMed
    Score: 0.328
  11. Amantadine for Antipsychotic-Related Weight Gain: Meta-Analysis of Randomized Placebo-Controlled Trials. J Clin Psychopharmacol. 2017 Jun; 37(3):341-346.
    View in: PubMed
    Score: 0.325
  12. Quality of life in Chinese patients with schizophrenia treated in primary care. Psychiatry Res. 2017 08; 254:80-84.
    View in: PubMed
    Score: 0.323
  13. Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials. J Psychiatr Res. 2017 09; 92:139-146.
    View in: PubMed
    Score: 0.322
  14. Longitudinal changes in prospective memory and their clinical correlates at 1-year follow-up in first-episode schizophrenia. PLoS One. 2017; 12(2):e0172114.
    View in: PubMed
    Score: 0.319
  15. Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009). Asia Pac Psychiatry. 2017 Dec; 9(4).
    View in: PubMed
    Score: 0.319
  16. Memory Impairment Following Electroconvulsive Therapy in Chinese Patients with Schizophrenia: Meta-Analysis of Randomized Controlled Trials. Perspect Psychiatr Care. 2018 Apr; 54(2):107-114.
    View in: PubMed
    Score: 0.318
  17. Cannabis use correlates with aggressive behavior and long-acting injectable antipsychotic treatment in Asian patients with schizophrenia. Nord J Psychiatry. 2019 Aug; 73(6):323-330.
    View in: PubMed
    Score: 0.094
  18. ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials. J Psychiatr Res. 2018 10; 105:23-32.
    View in: PubMed
    Score: 0.088
  19. Combination of Metformin and Lifestyle Intervention for Antipsychotic-Related Weight Gain: A Meta-Analysis of Randomized Controlled Trials. Pharmacopsychiatry. 2019 Jan; 52(1):24-31.
    View in: PubMed
    Score: 0.086
  20. Effect of rs1344706 in the ZNF804A gene on the brain network. Neuroimage Clin. 2018; 17:1000-1005.
    View in: PubMed
    Score: 0.084
  21. The contribution of the contingent negative variation (CNV) to goal maintenance. Schizophr Res. 2018 05; 195:372-377.
    View in: PubMed
    Score: 0.083
  22. Prevalence of smoking in patients with bipolar disorder, major depressive disorder and schizophrenia and their relationships with quality of life. Sci Rep. 2017 08 16; 7(1):8430.
    View in: PubMed
    Score: 0.082
  23. Anticholinergic use trends in 14,013 patients with schizophrenia from three national surveys on the use of psychotropic medications in China (2002-2012). Psychiatry Res. 2017 11; 257:132-136.
    View in: PubMed
    Score: 0.082
  24. Association between schizophrenia and violence among Chinese female offenders. Sci Rep. 2017 04 11; 7(1):818.
    View in: PubMed
    Score: 0.081
  25. Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials. J Psychopharmacol. 2017 05; 31(5):625-631.
    View in: PubMed
    Score: 0.080
  26. Adjunctive antidepressant use in schizophrenia in China: A national survey (2002-2012). Hum Psychopharmacol. 2017 01; 32(1).
    View in: PubMed
    Score: 0.079
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.